Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CXCL5 is a small cytokine belonging to the CXC chemokine family, primarily acting as a chemoattractant for neutrophils via interaction with CXCR2. It plays roles in inflammation, angiogenesis, and connective tissue remodeling, and has been implicated in various pathological processes including inflammatory diseases, cancer, cardiovascular disease, and metabolic disorders.
CXCL5 binds primarily to CXCR2 on target leukocytes/neutrophils, modulating their activity. It can also bind Glycosaminoglycans to modulate availability/activity. When bound to GAGs, it cannot activate receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-X-C motif chemokine ligand 5 (CXCL5).